• Clinical Evidence

Glycemic Control in the Burn Intensive Care Unit, Focus on the Role of Anemia in Glucose Measurement

Setting: Largest (425-bed) U.S. military hospital, academic medical center and Level 1 trauma center.

Objective

This study examines glycemic control challenges in a burn patient population, effects of glycemic variability on outcomes, and benefits of a computerized decision support system (EndoTool) over a traditional paper protocol for the management of intensive insulin therapy.

Setting

Largest (425-bed) U.S. military hospital, academic medical center and Level 1 trauma center.

Results

  • Compared to a traditional paper protocol, EndoTool provided better glycemic control in the 80-110 mg/dL target range without increased hypoglycemic events.
  • Additionally, nurses accepted EndoTool insulin dosing recommendations more often than they followed a traditional paper protocol.

Conclusions

EndoTool outperforms a traditional paper protocol for the management of intensive insulin therapy and is considered standard of care for glucose control in a burn intensive care unit.
Objective

This study examines glycemic control challenges in a burn patient population, effects of glycemic variability on outcomes, and benefits of a computerized decision support system (EndoTool) over a traditional paper protocol for the management of intensive insulin therapy.

Setting

Largest (425-bed) U.S. military hospital, academic medical center and Level 1 trauma center.

Results
  • Compared to a traditional paper protocol, EndoTool provided better glycemic control in the 80-110 mg/dL target range without increased hypoglycemic events.
  • Additionally, nurses accepted EndoTool insulin dosing recommendations more often than they followed a traditional paper protocol.
Conclusions

EndoTool outperforms a traditional paper protocol for the management of intensive insulin therapy and is considered standard of care for glucose control in a burn intensive care unit.

References

Authors

Elizabeth Mann, RN; Alejandra Mora, BS; Heather Pidcoke, MD, Steven Wolf, MD, and Charles Wade, PhD.

Source

Published in Journal of Diabetes Science and Technology, Volume 3, Issue 6, p1319-1329.

Year

2009

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

This study examines glycemic control challenges in a burn patient population, effects of glycemic variability on outcomes, and benefits of a computerized decision support system (EndoTool) over a traditional paper protocol for the management of intensive insulin therapy.

Setting

Largest (425-bed) U.S. military hospital, academic medical center and Level 1 trauma center.

Results
  • Compared to a traditional paper protocol, EndoTool provided better glycemic control in the 80-110 mg/dL target range without increased hypoglycemic events.
  • Additionally, nurses accepted EndoTool insulin dosing recommendations more often than they followed a traditional paper protocol.
Conclusions

EndoTool outperforms a traditional paper protocol for the management of intensive insulin therapy and is considered standard of care for glucose control in a burn intensive care unit.

References

Authors

Elizabeth Mann, RN; Alejandra Mora, BS; Heather Pidcoke, MD, Steven Wolf, MD, and Charles Wade, PhD.

Source

Published in Journal of Diabetes Science and Technology, Volume 3, Issue 6, p1319-1329.

Year

2009

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

Near Elimination of Severe Hypoglycemia with EndoTool IV Across a 19-Hospital Health System

Near Elimination of Severe Hypoglycemia with EndoTool IV Across a 19-Hospital Health System

To evaluate the impact of EndoTool IV insulin dosing software on reducing severe hypoglycemia (SH) (blood glucose < 40 mg/dL) across 19-hospitals at a prominent health system, including outcomes in patients with renal insufficiency.
Image
  • Clinical Evidence

Temple Health Achieves Zero Severe Hypoglycemia in Renally Impaired Patients with EndoTool SubQ

Temple Health Achieves Zero Severe Hypoglycemia in Renally Impaired Patients with EndoTool SubQ

To evaluate the safety and efficacy of the EndoTool SubQ (ETSQ) insulin dosing application for subcutaneous (SQ) insulin administration in hospitalized patients, and to compare clinical outcomes against those treated using a standard insulin order set. The analysis also examined performance in high-risk patients with advanced renal impairment.
Image
  • Clinical Evidence

Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ

Improving Inpatient Glycemic Safety at Temple Health with EndoTool SubQ

Temple Health, a 3-hospital academic system was experiencing high rates of hypoglycemia due to reliance on sliding scale insulin (SSI). To improve safety and align with ADA guidelines, the hospital implemented EndoTool SubQ, a patient-specific insulin dosing software the supports four dosing protocols, including basal-bolus-correction (BBC).
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Name*
By submitting this form, you consent to the processing of your personal information, including sensitive personal information you provide, in accordance with the Monarch Medical Technologies Privacy Notice.